Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 April 2019 | Story Mamosa Makaya
National Lotteries Commission
Front row from the left: Dr MA Madzivhandila (board member), Prof YN Gordhan (board member), Ms Charlotte Mampane (Commissioner), Prof D Coetzee (South Campus Principal), Ms Bish B Ramahlele (Director: Community Engagement) Back row from the left T Mandyu (Provincial Manager), Prof NA Nevhutanda (Chairman of the Board), Mr F Van Der Wat (Deputy Director: KovsieSport)

The University of the Free State (UFS) has over many years embarked on developmental projects to improve and upgrade its sports facilities, sports research, medical research, arts and cultural programmes and community focused programmes. These projects were made possible with the financial support of the National Lotteries Commission (NLC) which has provided funding through grants to the UFS since 2006. The UFS office of Institutional Advancement (IA) hosted the NLC on the Bloemfontein Campus on 5 April 2019, where a presentation on the success of projects was made. The role of the IA office is to ensure that the university complies with reporting requirements set out in the grant agreements and that the university maintains good relations with the NLC over the long term.

Funding fortifies UFS projects
Feedback on the success and impact of various projects was presented, such as the visual arts project. This includes the public sculpture project funded with over R3 million in 2009, which brought about the creation of outdoor sculptures that can be seen on the university grounds produced by local and regional sculptors. Feedback was provided by Ms Angela de Jesus, Curator, UFS Arts Collection and Assistant Director: Johannes Stegmann Gallery.  

In 2010 the NLC funded the upgrading of the UFS swimming pool for more than R2 million. The pool was rebuilt to bring it up to Olympic standards, allowing UFS students to have a facility at which to train for international swimming competitions. Feedback on the project was provided by Mr Frans van der Wat, Deputy Director: KovsieSport. Other funded projects are the Khoisan early learning centre, which teaches young learners on the history and culture of the “first people” of South Africa, and the Arts in Schools Project, which were both funded in 2009 for more than R6 million combined. More funded projects include the upgrading of the Johannes Stegmann Gallery in 2017, research into swimming in the Free State, and equipment for the South African Doping Control Laboratory (SADOCol), which is the only laboratory of its kind in Africa, which were funded between 2010 and 2012, totalling R4.8million.

Community development and engaged scholarship
After the change in the mandate of the Provincial Arts Council of the Free State (PACOFS) after 1996, many local dramatic arts professionals in the province were faced with dwindling work opportunities. The UFS, through the Department of Drama and Theatre Arts, stepped in to create arts programmes that would help develop and retain the skills of local performers and playwrights and an opportunity for them to be trained and directed by UFS and industry-based professional directors. 

Prof Nico Luwes, from the UFS Department of Drama and Theatre Arts, said: “I initiated the formation of the Free State Theatre Acts (FACTS) as a section 21 Company with committee members from UFS staff and local actors, with the aim of creating work for professional actors in the greater Bloemfontein area.” A combination of grants from the NLC and the UFS Department of Drama, between 2006 and 2010 resulted in 19 professional plays and four professional musicals, performed by Free State professional artists including community players from Heidedal, Botshabelo and drama students, using English, Afrikaans and Sesotho. These initiatives brought together students and artists from different linguistic and cultural backgrounds, who worked together to perform at local and national arts festivals. Although the NLC will not be funding arts and culture projects at universities in the 2019-2020 financial year, the university is hopeful to be considered in the future.

The UFS and NLC have had a successful working relationship and the feedback session aimed to strengthen the ties between them. Members of the board of the NLC expressed pride at how the UFS has developed not only its own projects, but the Free State community as well. The team was treated to an art exhibition of the work of Cape Town-based artist Ieshaan Adams at the Johannes Stegmann gallery.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept